RE:RE:What could the next 18 months be worth? "4) IF they get a deal of somekind with any reputable drink co this could do big things for the SP."
The recent CoQ10 bioavailability results are so profound that CZO is now looking to sign a life sciences company first. People's health may may be at stake: "Diseases such as neurodegenerative diseases, fibromyalgia, diabetes, cancer, mitochondrial diseases, muscular diseases, and heart failure are associated with decreased circulating levels of CoQ10." Coenzyme Q10 - PubMed (nih.gov)
As Gilles talked about in CZO's presentation last week the results are so strong CZO's PGX may be able to hijack macrophages given the binding affinity and use macrophages to further deliver bioactives throughout the body for medical purposes. This is potentially very big:
- "Of interest, the size of PGX processed YBG particles (around 5 microns) would allow them to be “swallowable” by macrophages that would carry them to remote sites in the body. Thus, the loading of drugs onto PGX YBG is currently under further investigation, since numerous research studies suggest that YBG cells being swallowed by macrophages could be utilized as “Trojan Horses” to carry bioactives (potentially CoQ10, antioxidants, pain killers or potent pharmaceutical drugs) into the body to the target tissue." CZO news relase